- Funding
- Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
- Topic 2: Innovations to accelerate vaccine development and manufacture
- Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB) This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019).
- Topic 4: Tumour plasticity
- Topic 5: Proton versus photon therapy for oesophageal cancer – a trimodality strategy
- Topic 6: Handling of protein drug products and stability concerns
Indicative budget
- From EFPIA companies and IMI2 Associated Partners: EUR 140 209 500
- From the IMI2 JU: EUR 133 009 000
Key dates and deadlines
- Draft topic texts published: 15 October 2019
- Publication date: 21 January 2020
- Stage 1 submission start date: 21 January 2020
- Stage 1 submission deadline: 21 April 2020
- Stage 2 submission deadline: 5 November 2020
